A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC

NCT05378867 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer (CRC)

Interventions

BIOLOGICAL: TRS003
BIOLOGICAL: China-approved Bevacizumab
DRUG: mFOLFOX6

Sponsor

Zhejiang Teruisi Pharmaceutical Inc.